Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Hematopoietic Stem Cell Transplantation in Children With Sickle Cell Anemia: The Parents’ Experience
source: Pediatric Transplantation
year: 2019
authors: Cavadini R, Drain E, Bernaudin F, D'Autume C, Giannica D, Giraud F, Baubet T, Taïeb O
summary/abstract:Genoidentical HSCT is currently the only curative treatment for SCA, preventing further vascular complications in high-risk children. Studies on the psychological implications of HSCT for recipient, sibling donor, and the rest of the family have been limited in SCA. This study enrolled ten families and used semi-structured interviews to explore the parents’ experience at three time points: first before transplantation, then 3 months later, and 1 year later. Three themes emerged from the results: (a) the presence of anxiety, experienced throughout the process, and alleviated by coping strategies (positive thinking, family support, praying); (b) the ability to remain parents to recipient and other family members, despite apprehension and feelings of helplessness, reinforced by the mobilization of important resources at the individual/family levels; (c) the ability to acknowledge the opportunity for their child to be cured of the disease, despite feelings of guilt toward families without a donor, or their own families back home. Overall, the parental experience with HSCT is complex, involving intra-psychic, familial, cultural, religious, and existential factors. Thus, it is important for medical teams to be cognizant of these issues in order to provide the best support to families during the HSCT process.
organization: Hôpital Maison Blanche, France; Paris XIII University & Assistance Publique-Hôpitaux de Paris, France; Centre Hospitalier Intercommunal, FranceDOI: 10.1111/petr.13376
read more
Related Content
-
Jennell White, PhDDr. Jennell White is an Assistant Profes...
-
Trends in Sickle Cell Disease – Related Mortality in the United States, 1979 to 2017Study objective: We provide an updated ...
-
CDC grand rounds: Improving the lives of persons with sickle cell diseaseApproximately 100,000 Americans have sic...
-
SCDAA News Advisory: Partial Hold on Gene Therapy TrialOn December 20, the FDA placed a partial...
-
A multiple drug approach to preventing sickle cell crisisSickle cell disease is characterized by ...
-
2017 LEADERSHIP SUMMIT & GENERAL ASSEMBLYThe Sickle Cell Community Consortium is ...
-
Blood Transfusions: How, Why, and When? (Part 1)https://www.youtube.com/watch?v=KRjjp0Jw...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.